Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1559 |  LEGN Legend Biotech Corporation - American Depositary Shares | 18.71 USD | -2.14% | -3.16% | -7.47% | -41.49% | 3.46 B USD | ||
| 1573 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 19.58 USD | -0.36% | -2.20% | -29.13% | -6.58% | 3.37 B USD | ||
| 1584 |  CELC Celcuity Inc. - Common Stock | 67.87 USD | +3.18% | -9.66% | -23.20% | +38.12% | 3.32 B USD | ||
| 1598 |  VKTX Viking Therapeutics, Inc. - Common Stock | 27.73 USD | -2.84% | -10.11% | -14.68% | -22.54% | 3.23 B USD | ||
| 1617 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 72.22 USD | -1.89% | -4.77% | -16.32% | +9.32% | 3.17 B USD | ||
| 1640 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.49 USD | +1.32% | -3.96% | +3.68% | +18.14% | 3.08 B USD | ||
| 1646 |  DYN Dyne Therapeutics, Inc. - Common Stock | 16.37 USD | +2.50% | +2.12% | -15.53% | -30.07% | 3.06 B USD | ||
| 1658 |  RCUS Arcus Biosciences, Inc. Common Stock | 23.82 USD | -2.89% | -6.33% | -15.14% | +56.92% | 3.03 B USD | ||
| 1660 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.20 USD | -0.84% | -4.56% | -14.63% | +88.63% | 3.03 B USD | ||
| 1670 |  DNLI Denali Therapeutics Inc. - Common Stock | 18.67 USD | -2.56% | -10.46% | -13.92% | +15.46% | 2.98 B USD | ||
| 1673 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 40.63 USD | -1.76% | -14.25% | -31.19% | +96.66% | 2.98 B USD | ||
| 1720 |  ZLAB Zai Lab Limited - American Depositary Shares | 24.81 USD | -1.98% | +0.69% | -2.13% | -7.04% | 2.79 B USD | ||
| 1738 |  PGEN Precigen, Inc. - Common Stock | 7.60 USD | +0.80% | -8.43% | +13.43% | +136.76% | 2.72 B USD | ||
| 1787 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.26 USD | -3.93% | -13.58% | -16.13% | -41.38% | 2.54 B USD | ||
| 1788 |  BEAM Beam Therapeutics Inc. - Common Stock | 24.60 USD | -0.69% | -1.60% | -0.73% | -13.62% | 2.54 B USD | ||
| 1797 |  LQDA Liquidia Corporation - Common Stock | 28.02 USD | +5.02% | +4.98% | -58.42% | +23.98% | 2.51 B USD | ||
| 1839 |  IRON Disc Medicine, Inc. - Common Stock | 60.77 USD | -0.67% | -5.87% | -19.92% | -13.81% | 2.33 B USD | ||
| 1843 |  ADMA ADMA Biologics Inc - Common Stock | 10.33 USD | +1.87% | +3.09% | +10.01% | -30.11% | 2.31 B USD | ||
| 1851 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.60 USD | +0.66% | -0.45% | -5.74% | +28.16% | 2.31 B USD | ||
| 1852 |  NRIX Nurix Therapeutics, Inc. - Common stock | 22.21 USD | -2.29% | -6.37% | -16.00% | +98.13% | 2.30 B USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |